Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial

被引：0
|
作者：
Goette, Andreas
de Groot, Joris R.
Le Heuzey, Jean-Yves
Banach, Maciej
Huber, Kurt
Jin, James
Melino, Michael
Winters, Shannon M.
Themistoclakis, Sakis
Lip, Gregory
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Anticoagulants; Atrial fibrillation; Aging; Gender differences;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18190
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial
    Cohen, Ariel A.
    Heidbuchel, Hein
    Le Heuzey, Jean-Yves
    De Caterina, Raffaele
    Merino, Jose L.
    Jin, James
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y. H.
    AMERICAN HEART JOURNAL, 2019, 209 : 131 - 135
  • [12] HEALTH CARE COST IN PATIENTS UNDERGOING ELECTRICAL CARDIOVERSION: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY
    Barrrios, Rodriguez J.
    Goette, A.
    Kwong, J.
    Ezekowitz, M. D.
    Banach, M. S.
    Hjortshen, S. P.
    Zamcnyakhin, D.
    Lip, G.
    VALUE IN HEALTH, 2017, 20 (09) : A608 - A608
  • [13] The relationship of renal function to outcome: a post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) study
    Lip, G. Y. H.
    Al-Saady, N.
    Ezekowitz, M. D.
    Banach, M.
    Goette, A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1369 - 1369
  • [14] Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)
    Lip, Gregory Y. H.
    Merino, Jose L.
    Banach, Maciej
    de Groot, Joris R.
    Maier, Lars S.
    Themistoclakis, Sakis
    Boriani, Giuseppe
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (04): : 592 - 597
  • [15] The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
    Lip, Gregory Y. H.
    Al-Saady, Naab
    Ezekowitz, Michael D.
    Banach, Maciej
    Goette, Andreas
    AMERICAN HEART JOURNAL, 2017, 193 : 16 - 22
  • [16] EDOXABAN THERAPY INCREASES TREATMENT SATISFACTION AND REDUCES UTILIZATION OF HEALTH CARE RESOURCES: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY
    Goette, Andreas
    Kwong, Winghan
    Ezekowitz, Michael
    Banach, Maciej
    Hjortshoj, Soren
    Zamoryakhin, Dmitry
    Lip, Gregory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 454 - 454
  • [17] Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
    Goette, Andreas
    Merino, Jose L.
    Ezekowitz, Michael D.
    Zamoryakhin, Dmitry
    Melino, Michael
    Jin, James
    Mercuri, Michele F.
    Grosso, Michael A.
    Fernandez, Victor
    Al-Saady, Naab
    Pelekh, Natalya
    Zenin, Sergey
    Kushnir, Mykola
    Spinar, Jindrich
    Batushkin, Valeriy
    Lip, Gregory Y. H.
    Weitz, Jeffrey
    Freemantle, Nicholas
    Klein, Helmut
    Buller, Harry
    Segers, Annelise
    Roos, Yvo
    Slagboom, Ton
    Thijs, Vincent
    van Mechelen, Rob
    Larrey, Dominique
    Laleman, Wim
    Huber, Kurt
    Heidbuchel, Hein
    Goudev, Assen
    Kautzner, Josef
    Rasmussen, Lars
    Cohen, Ariel
    Le Heuzey, Jean-Yves
    Glikson, Michael
    Themistoclakis, Sakis
    De Caterina, Raffaele
    Banach, Maciej
    Dan, Gheorghe-Andrei
    Ruda, Mikhail
    Lundqvist, Carina Blomstrom
    Sychov, Oleg
    Ellenbogen, Kenneth
    Ezekowitz, Michael
    Gwechenberger, Marianne
    Huber, Kurt
    Purerfellner, Helmut
    Roithinger, Franz
    Scherr, Daniel
    Stuhlinger, Markus
    LANCET, 2016, 388 (10055): : 1995 - 2003
  • [18] Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study
    Goette, Andreas
    Kwong, Winghan J.
    Ezekowitz, Michael D.
    Banach, Maciej
    Hjortshoj, Soren P.
    Zamoryakhin, Dmitry
    Lip, Gregory Y. H.
    EUROPACE, 2018, 20 (12): : 1936 - 1943
  • [19] Spontaneous Cardioversion in Nonvalvular Atrial Fibrillation in Patients Planned for Electrical Cardioversion: A Subanalysis of the ENSURE-AF Trial
    Cohen, Ariel A.
    Heidbuchel, Hein
    Le Heuzey, Jean-Yves
    De Caterina, Raffaele
    Merino, Jose L.
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y.
    CIRCULATION, 2017, 136
  • [20] Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial
    Lip, Gregory Y.
    Al-Saady, Naab
    Jin, James
    Sun, Ming
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    Zamoryakhin, Dmitry
    CIRCULATION, 2016, 134
12345